Clinical Trials
2 trialsNCT04107142 2019-09-27
Haplo / Allogeneic NKG2DL-targeting Chimeric Antigen Receptor-grafted γδ T Cells for Relapsed or Refractory Solid Tumour
CytoMed Therapeutics Pte Ltd
Phase 1 Unknown
NCT03047525 2017-02-09
Study of DC-CTL Combined With CIK for Advanced Solid Tumor
Harbin Medical University
Phase 1/2 Unknown